ライフサイエンスコーパス: nonsignificant

1 d recurrences (1/23 [4%] versus 2/67 [3%]; P=nonsignificant).

2 sed Classification (0.81, 95% CI, 0.74-0.88; nonsignificant).

3 uding tacrolimus trough concentrations, were nonsignificant).

4 n group 3; P values for all comparisons were nonsignificant).

5 847 +/- 68 kcal, respectively) were similar (nonsignificant).

6 ZPL-3893787 compared with placebo at week 8 (nonsignificant).

7 ing, highly suggestive, suggestive, weak, or nonsignificant.

8 uent VE among Canadian inpatients was mainly nonsignificant.

9 hile in United Kingdom and Alps, trends were nonsignificant.

10 98)], whereas HRs in cis MUFA quintiles were nonsignificant.

11 specifically were positive but imprecise and nonsignificant.

12 The additional effect of PARI was small and nonsignificant.

13 apparent diffusion coefficient was weak and nonsignificant.

14 ined significant, but bleeding events became nonsignificant.

15 L1 genotype on renal allograft survival were nonsignificant.

16 All meta-analyses were nonsignificant.

17 = .005) and the effect of cigarette use was nonsignificant.

18 malities at follow-up rendered this increase nonsignificant.

19 labor market status interactions) and mainly nonsignificant.

20 61-1.95), whereas the genetic estimates were nonsignificant.

21 IN3+ (P = 0.0625) lesions were statistically nonsignificant.

22 placebo; P = .06); however, this finding was nonsignificant.

23 carriers and Pnc-neg groups were smaller or nonsignificant.

24 between menopausal status and treatment were nonsignificant.

25 ies diversity, from positive to negative and nonsignificant.

26 ing associations for IL-1RA or TGF-beta were nonsignificant.

27 t that after day 30 these differences became nonsignificant.

28 the event group to turn a significant result nonsignificant.

29 +/-5.7 and 10.3+/-5.2 years, respectively [P=nonsignificant]).

30 and westslope cutthroat trout experiencing a nonsignificant 1% increase.

31 Analysis by intention-to-treat showed a nonsignificant 14% relative reduction in the primary out

32 control, 251 deaths occurred, representing a nonsignificant 15% lower risk in the active intervention

33 ebrafish showed increased variation in and a nonsignificant 15% prolongation of action potential dura

34 There was a nonsignificant 16.3% increase in monthly yield of CT pul

35 A nonsignificant 17% reduction in the annualized rate of s

36 whereas the %T >10 throughout the day was a nonsignificant 22% less after the no-carbohydrate breakf

37 tdiagnosis TV watching was associated with a nonsignificant 25% increase in all-cause mortality risk

38 ents treated for 30 months, at the cost of a nonsignificant 34% increase in severe bleeding (1.34; 95

39 ylon fibers (ANOVA, P < 0.01) resulting in a nonsignificant 40% decrease in algal ingestion rates (AN

40 ent (AHR, 1.29; 95% CI, 1.17 to 1.41), and a nonsignificant 7% increased risk of outpatient psychiatr

41 stment (8.0% vs 6.6%; AOR, 1.00 [0.94-1.06]; nonsignificant absolute difference, -0.01% [-0.37% to 0.

42 This yielded an overall nonsignificant adjusted odds ratio (OR) of 1.3 (95% conf

43 time intensivist physician staffing remained nonsignificant (adjusted odds ratio, 0.90; 95% CI, 0.70-

44 r time, this difference decreased and became nonsignificant after 24 mo.

45 Benefit became nonsignificant after 7.3 hours.

46 dictors, but associations were attenuated or nonsignificant after additional adjustment for inflammat

47 rend=0.007); however, the association became nonsignificant after additional adjustment for VAT volum

48 Results remained nonsignificant after adjustment for age, sex, percentage

49 and diabetes, all other associations became nonsignificant after adjustment for BMI and waist circum

50 fined to those age 18 to 64 years and became nonsignificant after adjustment for differences in insur

51 ation between hsCRP and health status became nonsignificant after adjustment for sociodemographics, c

52 retinal vessel caliber and heart failure was nonsignificant after adjustment for systolic blood press

53 ks: 1.09-1.12), but results for class 2 were nonsignificant after adjustment.

54 ons with yogurt and eggs were attenuated and nonsignificant after exclusion of the first 4 years of f

55 of dental services was attenuated and became nonsignificant after individual adjustment for total hea

56 Yet, these differences were nonsignificant after multiple-testing correction, sugges

57 t, irrespective of dose, relatively small or nonsignificant alcohol effects emerged in other processi

58 isk was numerically higher but statistically nonsignificant among HBV/HCV coinfected (hazards ratio [

59 tion in men; although both associations were nonsignificant among women, no interaction was observed

60 0 years) rather than age group, results were nonsignificant and concordant for both studies.

61 hock during their acute hospitalization with nonsignificant and inconsistent trends noted over time i

62 rial contrast enhancement parameters, showed nonsignificant and mostly negligible correlations.

63 ss risk of death in blacks versus whites was nonsignificant and not affected by adjustment for covari

64 n success (23/26 [89%] versus 67/73 [92%]; P=nonsignificant) and recurrences (1/23 [4%] versus 2/67 [

65 cleotide polymorphism-based heritability was nonsignificant, and no significant genetic correlations

66 ded geographic site, there was an attenuated nonsignificant association between racial composition in

67 A weaker, nonsignificant association between vancomycin plus TZP a

68 justed beta = 37, 95% CI: 4, 70); a similar, nonsignificant association was observed for EAs (adjuste

69 .94; 95% CI, 0.90-0.99; p = 0.01), whereas a nonsignificant association was seen between higher strai

70 n multivariable-adjusted models, we observed nonsignificant associations among women in the highest v

71 ylaxis in high-risk children primarily found nonsignificant associations on prevention of asthma in s

72 Larger but nonsignificant associations were observed after further

73 Overall, mainly nonsignificant associations were observed.

74 osure variables generally showed similar but nonsignificant associations.

75 ween the highest and the lowest quartile was nonsignificant at 1.06 with a 95% confidence interval sp

76 es between patient groups were statistically nonsignificant at 3 (P = .397), 6 (P = .468), and 12 mon

77 initial tap-and-injection had statistically nonsignificant better average initial vision, but worse

78 ctivity were consistent and differences were nonsignificant between groups throughout the study.

79 Parts A and B and was rendered statistically nonsignificant by APOE epsilon4 in both samples (beta =

80 3830 (61.4%) to 4152 (66.6%) compared with a nonsignificant change from 5049 (61.8%) to 5044 (61.7%)

81 Nonsignificant changes in acellular cementum did not app

82 atients compared with CCL-CD- patients, with nonsignificant changes in the other group.

83 atients compared with CCL-CD- patients, with nonsignificant changes in the other group.

84 (respectively, 38.6 versus 41.0 months, P = nonsignificant) CONCLUSIONS: NAFLD-HCC is more often det

85 This second analysis showed a positive but nonsignificant correlation between the eCa response and

86 Conversely, there were nonsignificant correlations between 3moPFS and 6moPFS wi

87 r as well as other itch-related measures and nonsignificant correlations with scales hypothesized to

88 atients in the highest risk quintile, with a nonsignificant cost difference of $941 per patient ($537

89 mortality of 4.2% vs 5.8% (P < .001), with a nonsignificant cost difference of -$862 ($33513 vs $3437

90 rneal endothelium, demonstrating a small and nonsignificant decline in central CECD compared with bas

91 8%; 95% CI, -12.7% to -2.8%; P = .002) and a nonsignificant decline in stroke (-3.6%; 95% CI, -7.6% t

92 n the United States, Japan, and Spain, and a nonsignificant decrease in Canada.

93 Comparison of outcomes over time showed a nonsignificant decrease in conversions (right: 14 [13%]

94 There was a nonsignificant decrease in diaphragm tetanic force produ

95 95% confidence interval [CI], 0.52, 0.76), a nonsignificant decrease in short-term all-cause mortalit

96 f evidence B (30.5% to 39.8%; P = .17) and a nonsignificant decrease in the use of level of evidence

97 onsidering adult males only, while a slower, nonsignificant decrease of 4.4% per year was found for a

98 , 95% confidence interval: 0.28, 0.99) and a nonsignificant decreased risk of Crohn's disease (hazard

99 Trends of nonsignificant decreased VE among patients repeatedly va

100 .35; 95% confidence interval, .15-.84), with nonsignificant decreases in the risk of low birth weight

101 n, based on morphometric measurements, had a nonsignificant decreasing tendency between 1997 and 2005

102 milar reduction with placebo, resulting in a nonsignificant difference (P = .249).

103 s 19.91 for the secondary intention group, a nonsignificant difference (P = .41).

104 tment is beneficial, despite a statistically nonsignificant difference for the primary outcome, or di

105 ly, a meta-analysis of folic acid revealed a nonsignificant difference from placebo.

106 ceiving alemtuzumab (P = 0.001), there was a nonsignificant difference in antibody-mediated rejection

107 ence interval: 1.10 to 3.41; p = 0.02) and a nonsignificant difference in the risk for the composite

108 nd 7.65 +/- 7.83 mm(2) from NIR, with a mean nonsignificant difference of 0.31 +/- 0.55 mm(2) (2-tail

109 A similar but nonsignificant difference was found for predicting hospi

110 dy T2D score, but prediction improvement was nonsignificant (difference in C-index 0.02, 95% CI -0.08

111 end point (HR, 0.68; 95% CI, 0.47-1.00) but nonsignificant differences in the rates of bleeding (0.9

112 Nonsignificant differences were found in unaffected sibl

113 Twenty-one outcomes showed nonsignificant differences, including BPD (55.2% with hy

114 ly following the intervention, followed by a nonsignificant downward trend of 0.36 per 1,000 patient

115 aucoma patients (n = 33) also demonstrated a nonsignificant effect of injections (-0.568 mum/year; 95

116 A nonsignificant effect of naltrexone on heavy drinking wa

117 nce fell short of significance, and moderate nonsignificant effect sizes were observed on self-report

118 codone self-administration but had a weaker (nonsignificant) effect on context-induced reinstatement.

119 p = .04), and higher insulin (p = .01), with nonsignificant effects for cortisol and glucose.

120 Surprisingly, we observed nonsignificant effects of the fuel addition treatment on

121 Nonsignificant effects on phosphoinositide 3-kinase/Akt

122 ved yield in favorable conditions but showed nonsignificant effects under stress; they were therefore

123 Nonsignificant effects were observed in the expression o

124 Comparable, but nonsignificant, effects when comparing a small sample of

125 C (p = .022, Cohen's d = 0.95), with smaller nonsignificant elevations in the prefrontal cortex (p =

126 se exposed to hygienic parental smoking were nonsignificant (episodic memory and associative learning

127 insulin, and C-reactive protein were mainly nonsignificant, especially after accounting for egg cons

128 Increased but nonsignificant estimated risks were also found for women

129 There were no acute allergic reactions or nonsignificant excesses of 6-month mortality (5.7% CsA v

130 t vary significantly by age, and there was a nonsignificant female predominance.

131 ndividual lifespan trajectories that lead to nonsignificant findings in adolescent and adult groups d

132 n the substantia nigra (-17%; p < 0.005) and nonsignificant findings in the putamen (-4%; p = 0.06).

133 The payment-volume elasticity was nonsignificant for 4 of 6 procedures studied: laser trab

134 he order: Clip > BSAF > BPAF > BAF, and were nonsignificant for BAF.

135 ifferences between groups were statistically nonsignificant for both variables (P = .580 and P = .669

136 diac cells to CoE is thought to be minor and nonsignificant for coronary formation.

137 95% CI, 1.30-2.80]; P<0.001) but smaller and nonsignificant for surgical premature menopause.

138 ients without LBBB, the benefit of CRT-D was nonsignificant for the first HHF (hazard ratio, 0.96; P=

139 Results were similar in trend, but nonsignificant, for the fewer centers with 6- to 7-year-

140 effort as very light to fairly light, with a nonsignificant gradual increase in the Borg score as the

141 .65; p = 9.40 x 10-5) and with statistically nonsignificant higher odds of head and neck (OR 1.40; 95

142 azard ratio, 1.12 [1.06-1.19]), leading to a nonsignificant higher relative risk in women (risk ratio

143 e groups had similar percentages of fat (P = nonsignificant); however, alveolar bone loss was signifi

144 The nonsignificant HRs for 1 year or more of thiopurine and

145 interval (CI), 1.01-1.86], with similar but nonsignificant HRs for 6-month persistent infections.

146 ificant signals among groups of individually nonsignificant hypotheses in examples of a human GWAS fo

147 Although differences were nonsignificant, IC plus cetuximab seemed to be the least

148 33%) or refractory (12 patients, 13%) had a nonsignificant impact on hospital mortality (odds ratio

149 mensions of diversity, including negligible (nonsignificant) impacts on local taxonomic richness (i.e

150 Mild hypothermia was associated with a nonsignificant improvement in 1-year kidney transplant s

151 0 [65] vs 319 [147] mL; P < .001) but only a nonsignificant improvement in the overall distribution o

152 In conclusion, the nonsignificant improvement of risk prediction does not s

153 nalysis, but the estimate was attenuated and nonsignificant in adjusted analysis (adjusted hazard rat

154 ; both p < .05), while this relationship was nonsignificant in HC and in both groups in the visual co

155 reductions that were significant in RAC and nonsignificant in LAC.

156 led to positive trends, albeit statistically nonsignificant in some cases, on memory performance, amy

157 This association became statistically nonsignificant in subjects with ACCI scores of 1-2 or >=

158 % CI, 1.06-1.19; P < 0.001), although it was nonsignificant in the multivariate model.

159 und at intakes <5E% [23% in the MDCS and 9% (nonsignificant) in the NSHDS].

160 onstrate any significant change but showed a nonsignificant increase from 5.5% at baseline to 6.1% at

161 a tendency toward a larger but statistically nonsignificant increase in apparent diffusion coefficien

162 P = 0.03) in those with a TT genotype, but a nonsignificant increase in composite endpoint risk (haza

163 ces in markers of bone turnover; there was a nonsignificant increase in CTX levels in the dexlansopra

164 We observed a nonsignificant increase in estimated monthly drinks in t

165 erage native T1 was 1008 msec +/- 31, with a nonsignificant increase in females (1017 msec +/- 27 vs

166 Empagliflozin caused a nonsignificant increase in fractional excretion of sodiu

167 HR, 0.79; 95% CI, 0.67-0.94; P=0.008) and a nonsignificant increase in hemorrhagic stroke (0.8% vers

168 The nonsignificant increase in incidence and IB mortality in

169 0.02+/-0.03% at 12 months (P < 0.0001) and a nonsignificant increase in ischemic index from 5.9+/-4.5

170 There was also a nonsignificant increase in maternal postpartum retention

171 ion with population density was poor, with a nonsignificant increase in SCAs with population density

172 One trial showed a statistically nonsignificant increase in suicidal ideation with venlaf

173 ticholinergic Drug Scale score resulted in a nonsignificant increase in the probability of delirium o

174 5% CI, 0.39-0.88]; P = .01), and there was a nonsignificant increase in the proportion of appropriate

175 spiration thrombectomy was associated with a nonsignificant increase in the risk of stroke 0.6% versu

176 Numerically, there was a nonsignificant increase in the use of level of evidence

177 Glyburide-exposed neonates had a nonsignificant increase in total fat mass (103.2 g, 95%

178 Average ECV was 20.8% +/- 2.4, with a nonsignificant increase in values in females (21.7% +/-

179 ally controlled asthma was associated with a nonsignificant increase of $9.5 (95% CI -$13.6 - $32.6)

180 one HPV vaccination outcome, one reported a nonsignificant increase, and one reported mixed effects.

181 Dechlorane plus showed a nonsignificant increase.

182 Overall, there was a statistically nonsignificant increased risk in long-term (2- to 5-year

183 ase did not persist beyond this period, with nonsignificant increases 3 and 4 cumulative years after

184 Vitamin D was associated with nonsignificant increases in maternal lead and with signi

185 per urinary tract cancer revealed slight but nonsignificant increases in the ORs for localized diseas

186 This analysis showed a positive, but nonsignificant interaction effect (95% CI for above-grou

187 se dementia among Hp(+) individuals, despite nonsignificant interaction.

188 he multiple regression analysis, and whether nonsignificant interactions were true or caused by insuf

189 fter the first rotavirus dose with modest or nonsignificant interference after completion of the full

190 A nonsignificant inverse association was observed between

191 For BPA, we observed a nonsignificant inverse association with total 25(OH)D in

192 0.97) and IHD (0.86; 0.75, 0.97), as well as nonsignificant inverse associations for risk of stroke (

193 Nonsignificant inverse associations were observed for hi

194 For VLCSFAs in erythrocytes, a nonsignificant inverse trend with CHD risk was observed

195 nd copepods exposed to nylon granules showed nonsignificant lipid accumulation (ANOVA, P = 0.62).

196 Use of the SDA was associated with a nonsignificant lower perinatal mortality of 14 per 1000

197 confidence interval 0.23-0.73; P=0.003), and nonsignificant lower risk of stroke and thromboembolic e

198 , associations were substantially weaker and nonsignificant (moderate smoking during pregnancy: HR, 1

199 Smaller and largely nonsignificant molecular changes were seen in the 20-mg

200 Specifically, we found a nonsignificant negative correlation between T2D and POAG

201 odds ratio for recent femoral proportion was nonsignificant (odds ratio, 0.99; 95% confidence interva

202 also trends toward increased risks, although nonsignificant, of myocardial infarction and ischemic st

203 parameter combinations and was offset (i.e., nonsignificant) only for dramatic increases in different

204 ; results for quality of life were generally nonsignificant or showed an effect only on some subscale

205 Nonsignificant ORs of exposure to inhaled beta2-agonists

206 Elevated but nonsignificant ORs were estimated for the highest versus

207 in productivity, but that this effect became nonsignificant over later years of the experiment, with

208 POAG were low (r(g) range -0.18 to 0.11) and nonsignificant (P >= .07).

209 ough the gene-dietary fat interaction became nonsignificant (P = 0.30).

210 ally significant compared with those classed nonsignificant (P<0.001).

211 eduction by PARI beyond the effect of LS was nonsignificant (P=0.60).

212 .1+/-1.0, 5.9+/-1.2 and 5.3+/-0.5 fmol/mL (P=nonsignificant, P<0.0001, and P<0.0001, respectively).

213 lues of BMO-MRW tended to have a higher, but nonsignificant, pAUC across all sectors compared with RN

214 ed to expected ratios for the 2 programs was nonsignificant (Pearson product moment correlation, rho

215 eding 1.75 using National Quality Forum, but nonsignificant performance using Acute Physiology and Ch

216 ate HR for black vegans showed a similar but nonsignificant point estimate (HR: 0.69; 95% CI: 0.41, 1

217 ce interval, 1.09-1.79), with a similar, but nonsignificant, point estimate in the first trimester.

218 contrast, Tourette's syndrome had a smaller, nonsignificant polygenic component, predicting only 0.6%

219 d FFA [SMD=0.86 (95% CI: 0.50, 1.22)], and a nonsignificant positive association with leptin levels [

220 A small, nonsignificant positive effect on the Trailmaking A test

221 ended the intervention of interest despite a nonsignificant primary outcome.

222 In RCTs with statistically nonsignificant primary outcomes published in surgical jo

223 In all, 110 eligible RCTs with nonsignificant primary outcomes were appraised.

224 ), while controls demonstrated statistically nonsignificant progression (baseline, 8.3 [1.6], follow-

225 to render a statistically significant result nonsignificant, quantitatively estimates the robustness

226 LVAD speed and medication adjustments and a nonsignificant reduction in adverse events.

227 s no significant reduction in death or MI, a nonsignificant reduction in all primary endpoint compone

228 Glomerulopenia was associated with a nonsignificant reduction in GFR in the hypertensive grou

229 95% CI -288.01 to -94.74, p < 0.001) with a nonsignificant reduction in macrosomia risk (OR 0.32, 95

230 tration of BCG-Denmark was associated with a nonsignificant reduction in neonatal mortality rate (MRR

231 lls from PhtD-vaccinated adult mice led to a nonsignificant reduction in NP colonization density, whe

232 A nonsignificant reduction in shedding was associated with

233 LAA exclusion was associated with a nonsignificant reduction in stroke (7.9% versus 8.6%, P=

234 There was a marginally nonsignificant reduction in syncope in the fludrocortiso

235 es >/=90%, and in this subgroup, there was a nonsignificant reduction in the end point of mortality a

236 There was a nonsignificant reduction in the first event of stroke of

237 on implemented by PCPs provided a modest but nonsignificant reduction in the incidence of major depre

238 ransplant with any bridging therapy showed a nonsignificant reduction in the risk of waitlist dropout

239 erence by v1 was suggested in 2012-2013 with nonsignificant reduction in VE when v1 approximately v2

240 overexpression of human miR-298 resulted in nonsignificant reduction of APP, BACE1, and tau in mice.

241 Application of the MYH7-ACMG resulted in a nonsignificant reduction of the VUS burden in both cohor

242 A statistically nonsignificant reduction was seen in the risk of high wa

243 ow to intermediate risk showed statistically nonsignificant reductions in early (OR, 0.67 [CI, 0.42 t

244 Nonresponders largely showed lesser/nonsignificant reductions in key inflammatory and barrie

245 tion (OR, 0.56; 95% CI, 0.43-0.73; P<0.001), nonsignificant reductions of stent thrombosis (OR, 0.46;

246 Single adversities tended to have nonsignificant relations with telomere length.

247 5% versus 0.2%; p = 0.03) with a similar but nonsignificant response to CFP-10.

248 .34 (95% CI, 1.18-1.53), although a similar, nonsignificant result was observed for acute kidney inju

249 folic acid, vitamin C, and tryptophan, with nonsignificant results for inositol.

250 controlled trials (RCTs) with statistically nonsignificant results for primary outcomes in surgical

251 a defined search strategy, RCTs with clearly nonsignificant results for the primary outcome (P > 0.05

252 Nonsignificant results were obtained for the last subgro

253 e, or distract the reader from statistically nonsignificant results) in published reports of randomiz

254 ificant results and D = 0.24 (0.11-0.42) for nonsignificant results.

255 s measured bereavement outcomes, with mostly nonsignificant results.

256 predictions, even though both analyses gave nonsignificant results.

257 me to AF sensitivity analyses showed similar nonsignificant results.

258 A statistically nonsignificant risk increase of 0.3% (95% CI: -0.4%, 1.5

259 The cohort study revealed an increased but nonsignificant risk of LTBI among diabetics (risk ratio,

260 n apoB levels and a corresponding attenuated nonsignificant risk of major cardiovascular events (OR,

261 lary and mandibular premolars demonstrated a nonsignificant RSA percentage at the evaluated CRRs.

262 ologically significant undergo PCI than when nonsignificant stenoses are treated.

263 nd alkali intake, p.E161K SNP carriers had a nonsignificant tendency to higher urinary pH on a random

264 ting glucose (-0.8 mmol/L; -1.8, 0.2 mmol/L, nonsignificant) than unexposed women.

265 HPeV showed a similar, yet nonsignificant trend (adjusted odds ratio, 1.44; 95% con

266 status in 1-month biopsy samples revealed a nonsignificant trend for higher regulatory T cell freque

267 degree of carotid stenosis, but there was a nonsignificant trend suggesting a higher risk of adverse

268 In subjects with CKD, there was a nonsignificant trend toward a better MACCE outcome with

269 and remained stable thereafter; there was a nonsignificant trend toward a flatter posterior KA and s

270 They had a nonsignificant trend toward a lower graft survival.

271 The 5-year survival was 73.1+/-2%, with a nonsignificant trend toward better survival in groups A

272 .31; 95% CI: 1.09, 1.58) and a statistically nonsignificant trend toward greater risk of relapse (RR:

273 in the Fe group (P = 0.013), and there was a nonsignificant trend toward higher Bifidobacterium spp.

274 There was a nonsignificant trend toward higher in-hospital stroke (O

275 covery Following Revascularization) showed a nonsignificant trend toward improved outcomes at 1 year

276 There was a nonsignificant trend toward improved sensitivity for dia

277 ibrillator use and outcomes, but there was a nonsignificant trend toward improved survival to hospita

278 for LT, the use of LRT is associated with a nonsignificant trend toward improved waitlist and posttr

279 ibit superoxide production associated with a nonsignificant trend toward increased FMDBA in the place

280 stratified by examination times, exhibited a nonsignificant trend toward increased positivity at prol

281 There was a nonsignificant trend toward less worsening in apathy and

282 compared with the placebo group, there was a nonsignificant trend toward lower daily activity (-381 a

283 There was a nonsignificant trend toward lower microvascular obstruct

284 There was a nonsignificant trend toward lower rates of GUSTO-defined

285 ConvLASIK eyes revealed a nonsignificant trend toward myopic regression from 3 to

286 BG performed between 24 to 72 hours showed a nonsignificant trend toward poorer long-term outcomes.

287 Further studies are needed to confirm the nonsignificant trend towards a lower graft survival in C

288 ting (P = .005), and nausea (P = .02), and a nonsignificant trend was found for pain (P = .054), refl

289 There were nonsignificant trends for larger amygdala and entorhinal

290 Subgroup analyses showed nonsignificant trends in which survival was greater for

291 post hoc high-risk subgroup analyses showed nonsignificant trends that seem to be in good agreement

292 Group A showed statistically nonsignificant trends toward improved freedom from pulse

293 ined variables nor were there any consistent nonsignificant trends.

294 l density analysis (p(corrected) < 0.05) but nonsignificant using activation-likelihood estimation.

295 5) BPA accumulation in roots than shoots and nonsignificant variances in biomass, chlorophyll (p > 0.

296 zed after 1 year (median SCD, 7443 mg of WP; nonsignificant vs low-dose VWG OIT).

297 w back pain, although this difference became nonsignificant when studies with high risk for bias were

298 esults in all six clinical outcomes (all p = nonsignificant) when compared to rivaroxaban users for t

299 relations of [(11)C]EKAP V(T) and BSMSS were nonsignificant with the exception of the insula.

300 r extreme rain following wet periods, albeit nonsignificant, with one of four relevant studies showin